Implications of Atopic Dermatitis on the Quality of Life of 6-11 Years Old Children and Caregivers (PEDI-BURDEN)
- PMID: 37077900
- PMCID: PMC10106808
- DOI: 10.2147/JAA.S404350
Implications of Atopic Dermatitis on the Quality of Life of 6-11 Years Old Children and Caregivers (PEDI-BURDEN)
Abstract
Purpose: Atopic dermatitis (AD) is a chronic, relapsing and remitting inflammatory skin disease characterized by intense itch. The disease burden includes physical limitations, psychosocial discomfort, and a reduced quality of life (HRQoL). This study presents the results of a parent-reported survey on the psychosocial impact of AD on Italian pre-adolescent children (6-11 years old), with a specific focus on bullying, self-isolation, absenteeism, and presenteeism.
Methods: An online questionnaire was sent to 3067 random recipients and 160 matched the inclusion criteria for age, self-reported AD diagnosis, localizations (according to ISAAC), and disease severity (POEM ≥8). 100 children, with comparable ages, not matching the inclusion criteria for AD, were recruited as a control group.
Results: Children with AD and their caregivers had a significantly lower quality of sleep (QoS) compared to the control group. The presence of AD was directly responsible for many restless nights, both in children and caregivers (58.9 and 55.4 respectively). Children with AD and their parents also experienced significantly more daytime drowsiness (43.6 and 54.6 days, respectively). Children with AD were more frequently victims of bullying at school (20.0% vs 9.0%; p≤0.05) or in other social environments (16.9% vs 3.0%; p≤0.05). AD caused 17.7 days of absenteeism and 20.1 days of presenteeism per student over the previous 12 months, accounting for 37.8 days of study impairment overall. Severe/very severe AD had a significantly greater impact on presenteeism than moderate AD (25.1 vs 17.5 days; p≤0.05). Presenteeism, which was more pronounced among bullied students, was positively correlated with absenteeism only in the AD cohort.
Conclusion: AD has a detrimental impact on the HRQoL of pediatric patients, causing stigmatization and social isolation. Functional distress was also reported by caregivers. Our study might inform the public and policymakers about the disease burden of AD at a young age.
Keywords: absenteeism; atopic dermatitis; daily drowsiness; presenteeism; sleep impairment.
© 2023 Neri et al.
Conflict of interest statement
I. Neri acts as advisor, speaker, investigator and/or consultant for Sanofi, Janssen, Roche-Posay, Giuliani, Leo Pharma. E. Galli reports scientific consultations and/or lectures for Lofarma, Hal_Allergy and Sanofi. I. Baiardini IB reports scientific consultations and/or lectures from Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Menarini, Novartis, Sanofi, Biofutura, Mundifarma, AstraZeneca. M. Picozza declares no conflicts of interest in this work. AB. Rossi, P. Matruglio, D. Moretti and F. Cipriani are Sanofi employees, and may hold stock and/or stock options in the company.
Figures
Similar articles
-
Atopic Dermatitis and Patient Perspectives: Insights of Bullying at School and Career Discrimination at Work.J Asthma Allergy. 2021 Jul 21;14:919-928. doi: 10.2147/JAA.S317009. eCollection 2021. J Asthma Allergy. 2021. PMID: 34321892 Free PMC article.
-
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.Dermatol Ther (Heidelb). 2023 Apr;13(4):951-960. doi: 10.1007/s13555-023-00899-y. Epub 2023 Feb 22. Dermatol Ther (Heidelb). 2023. PMID: 36811773 Free PMC article.
-
The disease burden of pediatric patients with atopic dermatitis in Japan.Pediatr Dermatol. 2023 Sep-Oct;40(5):851-856. doi: 10.1111/pde.15399. Epub 2023 Aug 15. Pediatr Dermatol. 2023. PMID: 37581214
-
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.Dermatol Ther (Heidelb). 2022 Dec;12(12):2653-2668. doi: 10.1007/s13555-022-00819-6. Epub 2022 Oct 5. Dermatol Ther (Heidelb). 2022. PMID: 36197589 Free PMC article. Review.
-
Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema.Int J Clin Pract. 2006 Aug;60(8):984-92. doi: 10.1111/j.1742-1241.2006.01047.x. Int J Clin Pract. 2006. PMID: 16893440 Review.
Cited by
-
European, multicentre, prospective observational phase IV clinical study to assess the impact of lebrikizumab on health-related well-being and control of skin manifestations in patients with moderate-to-severe atopic dermatitis (ADTrust): study protocol.BMJ Open. 2025 Jul 11;15(7):e102155. doi: 10.1136/bmjopen-2025-102155. BMJ Open. 2025. PMID: 40645621 Free PMC article.
-
The Impact and Burden of Chronic Rhinosinusitis with Nasal Polyps on Patients and Their Family Caregivers: A Nationally Representative Survey.Healthcare (Basel). 2025 Feb 17;13(4):430. doi: 10.3390/healthcare13040430. Healthcare (Basel). 2025. PMID: 39997305 Free PMC article.
-
The Efficacy and Effectiveness of the Biological Treatment of Pruritus in the Course of Atopic Dermatitis.J Clin Med. 2024 Mar 18;13(6):1754. doi: 10.3390/jcm13061754. J Clin Med. 2024. PMID: 38541978 Free PMC article. Review.
-
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case Series.Adv Ther. 2025 Jul;42(7):3186-3206. doi: 10.1007/s12325-025-03150-6. Epub 2025 May 8. Adv Ther. 2025. PMID: 40338484 Free PMC article. Clinical Trial.
-
The impact of atopic dermatitis on caregivers' quality of life in Ethiopia.Front Med (Lausanne). 2025 Mar 12;12:1537089. doi: 10.3389/fmed.2025.1537089. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40144873 Free PMC article.
References
LinkOut - more resources
Full Text Sources
Research Materials